ASX Announcement NOTICE OF DATE OF ANNUAL GENERAL MEETING AND OTHER RELEVANT DATES Melbourne, Australia – 12 August 2026: Pursuant to ASX Listing Rule 3.13.1 Percheron Therapeutics Limited (ASX: PER) ( Percheron or the Company ) is pleased to advise the following details...
Notice of date of AGM and other relevant dates
Filed with ASX · · 1 page · English
Release
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Percheron Therapeutics Announces CEO Succession
- Quarterly Activities Report and Appendix 4C
- Results of Entitlement Offer
- Prospectus - Non-renounceable Entitlement Offer
- Non-renounceable Entitlement Offer
Later from Percheron Therapeutics
- Application for quotation of securities - PER
- Appendix 4E and Annual Report
- Appendix 4G and Corporate Governance Statement
- Vanderbilt Health to conduct clinical trial of HMBD-002
- Trading Halt
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics